Halozyme Therapeutics Balance Sheet (2010-2025) | HALO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	499.45M	446.97M	491.68M	118.72M	117.83M	90.93M	147.16M	234.19M	96.38M	221.16M	274.23M	118.37M	164.63M	187.86M	154.32M	115.85M	176.33M	61.86M	419.67M	133.82M
Short-term Investments (Quarter)	264.86M	308.34M	324.24M	622.20M	668.30M	118.43M	118.42M	128.60M	179.22M	127.11M	209.06M	217.63M	298.82M	341.17M	511.99M	480.22M	571.59M	486.32M	282.30M	9.00M
Cash & Current Investments (Quarter)	764.31M	755.31M	815.92M	740.92M	786.14M	209.36M	265.58M	362.79M	275.61M	348.27M	483.28M	336.00M	463.45M	529.03M	666.31M	596.07M	747.92M	548.18M	701.96M	142.82M
Receivables - Net (Quarter)	89.50M	154.52M	113.30M	92.11M	113.76M	191.77M	235.07M	231.07M	200.80M	246.18M	217.32M	234.21M	195.90M	214.52M	285.74M	308.45M	304.62M	316.34M	346.04M	441.27M
Receivables - Other (Quarter)	30.00M					9.98M	69.20M		32.30M	0.24M	3.30M	1.00M				20.30M
Receivables (Quarter)	119.50M	154.52M	113.30M	92.11M	113.76M	201.75M	304.27M	231.07M	233.10M	246.42M	220.62M	235.21M	195.90M	214.52M	285.74M	328.75M	304.62M	316.34M	346.04M	441.27M
Raw Materials (Quarter)	6.04M	8.01M	8.11M	10.67M	10.27M	10.19M	11.96M	13.79M	22.45M	24.21M	26.93M	23.65M	29.11M	27.22M	30.58M	24.02M	18.42M	17.79M	18.96M	21.87M
Work In Process (Quarter)	19.44M	20.99M	21.72M	17.45M	6.33M	44.16M	56.24M	44.10M	27.40M	50.34M	37.57M	34.02M	43.61M	36.69M	14.89M	30.17M	36.65M	30.93M	34.84M	30.92M
Finished Goods (Quarter)	32.87M	29.56M	26.15M	25.79M	31.16M	43.26M	35.07M	45.97M	57.67M	57.86M	64.42M	69.93M	95.82M	126.64M	143.52M	142.94M	143.24M	164.87M	161.59M	144.45M
Inventory (Quarter)	58.34M	58.55M	55.98M	53.91M	47.76M	97.61M	103.28M	100.12M	107.52M	132.41M	128.92M	127.60M	168.54M	159.31M	131.41M	141.86M	164.87M	181.50M	185.80M	176.47M
Prepaid Assets (Quarter)	44.68M	32.69M	33.30M	40.48M	41.03M	71.88M	76.82M	71.33M	37.01M	57.29M	49.48M	48.61M	63.01M	106.17M	123.67M	119.55M	100.23M	133.02M	150.65M	64.64M
Current Assets (Quarter)	941.72M	999.75M	1,017.30M	926.29M	988.69M	541.94M	653.20M	739.01M	615.02M	765.75M	879.01M	746.42M	873.58M	987.80M	1,126.98M	1,085.34M	1,262.03M	1,122.67M	1,328.75M	825.21M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	10.37M	10.13M	9.59M	8.79M	8.51M	37.09M	36.67M	75.57M	77.96M	74.56M	74.67M	74.94M	78.07M	75.00M	74.49M	75.03M	72.82M	71.52M	71.42M	82.14M
Goodwill (Quarter)						199.48M	199.48M	409.05M	416.22M	416.82M	416.82M	416.82M	416.82M	416.82M	416.82M	416.82M	416.82M	416.82M	416.82M	580.36M
Intangibles (Quarter)						976.10M	948.90M	546.65M	528.82M	510.98M	490.64M	472.88M	455.12M	437.35M	419.59M	401.83M	384.07M	366.31M	348.54M	981.47M
Goodwill & Intangibles (Quarter)						1,175.58M	1,148.38M	955.70M	945.04M	927.80M	907.46M	889.70M	871.94M	854.17M	836.41M	818.65M	800.89M	783.13M	765.37M	1,561.83M
Long-Term Deferred Tax (Quarter)			142.48M	155.43M	142.51M			44.43M	35.68M	23.92M	13.41M	4.39M	0.62M			3.85M	5.19M	20.21M
Other Non-Current Assets (Quarter)	14.00M	15.48M	0.50M	2.10M	0.50M	6.85M	0.50M	0.50M	7.42M	18.41M			12.95M	52.48M	80.15M	17.40M	14.73M	56.37M	55.70M	2.60M
Non-Current Assets (Quarter)	24.86M	26.11M	168.12M	178.14M	173.56M	1,239.45M	1,211.34M	1,102.50M	1,084.43M	1,044.69M	1,013.66M	986.85M	967.94M	981.66M	991.05M	978.14M	934.50M	931.23M	892.48M	1,700.12M
Assets (Quarter)	966.58M	1,025.86M	1,185.42M	1,104.43M	1,162.25M	1,781.39M	1,864.54M	1,841.51M	1,699.45M	1,810.44M	1,892.66M	1,733.27M	1,841.53M	1,969.45M	2,118.03M	2,063.48M	2,196.53M	2,053.90M	2,221.23M	2,525.32M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.54M	4.56M	3.32M	1.54M	1.27M	12.23M	18.17M	17.69M	8.70M	10.12M	19.32M	11.82M	13.32M	15.43M	12.40M	10.25M	20.07M	18.69M	15.36M	20.90M
Payables (Quarter)	0.54M	4.56M	3.32M	1.54M	1.27M	12.23M	18.17M	17.69M	8.70M	10.12M	19.32M	11.82M	13.32M	15.43M	12.40M	10.25M	20.07M	18.69M	15.36M	20.90M
Accumulated Expenses (Quarter)	16.10M	19.27M	18.34M	24.44M	19.13M	84.10M	74.32M	99.76M	79.98M	105.43M	95.20M	100.68M	118.31M	117.93M	96.42M	128.85M	130.31M	115.59M	111.18M	156.19M
Short term Debt (Quarter)	89.04M	89.17M	89.25M	89.42M	89.55M	99.05M	13.31M	13.33M											710.68M
Current Deferred Revenue (Quarter)	1.75M	5.27M	2.25M	4.28M	1.75M	6.87M	3.59M	3.25M	3.25M	3.10M	0.67M
Total Current Liabilities (Quarter)	107.42M	114.25M	113.15M	117.15M	111.69M	199.51M	109.38M	130.79M	91.92M	116.39M	115.19M	112.49M	131.64M	133.36M	108.81M	139.10M	150.38M	134.28M	837.23M	177.09M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)				787.25M			1,491.16M	1,492.77M	1,494.38M	1,496.00M	1,497.62M	1,499.25M	1,500.88M	1,502.52M	1,504.15M	1,505.80M	1,507.45M	1,509.10M	800.07M	2,142.63M
Non-Current Deffered Revenue (Quarter)	4.03M	4.03M	2.53M	2.53M	2.03M	2.74M	2.83M	2.25M	2.25M	2.25M	2.25M
Non-Current Deferred Tax Liability (Quarter)						3.29M	28.99M							13.65M	11.95M	100.41M			8.22M	231.91M
Other Non-Current Liabilities (Quarter)	2.81M	2.27M	1.61M	0.54M	0.17M	130.00M	129.77M	15.47M	29.57M	13.89M	28.42M	37.72M	31.20M	30.51M	40.41M	54.76M	56.44M	77.77M	71.80M	113.86M
Total Non-Current Liabilities (Quarter)	896.18M	903.85M	902.14M	906.93M	901.82M	1,358.22M	1,637.78M	1,656.24M	1,604.02M	1,645.52M	1,615.06M	1,611.74M	1,632.52M	1,649.52M	1,624.92M	1,644.90M	1,657.83M	1,643.38M	1,645.52M	2,362.65M
Total Liabilities (Quarter)	898.99M	906.12M	903.75M	907.48M	901.99M	1,488.22M	1,767.55M	1,671.71M	1,633.60M	1,659.41M	1,643.48M	1,649.46M	1,663.72M	1,680.03M	1,665.33M	1,699.66M	1,714.26M	1,721.15M	1,717.32M	2,476.51M
Shareholder's Equity
Total Debt (Quarter)	89.04M	89.17M	89.25M	876.67M	89.55M	99.05M	1,504.47M	1,506.10M	1,494.38M	1,496.00M	1,497.62M	1,499.25M	1,500.88M	1,502.52M	1,504.15M	1,505.80M	1,507.45M	1,509.10M	1,510.76M	2,142.63M
Common Equity (Quarter)	67.59M	119.75M	281.67M	196.95M	260.26M	293.17M	96.99M	169.80M	65.85M	151.03M	249.18M	83.81M	177.81M	289.42M	452.70M	363.82M	482.27M	332.75M	503.92M	48.81M
Shareholder's Equity (Quarter)	67.59M	119.75M	281.67M	196.95M	260.26M	293.17M	96.99M	169.80M	65.85M	151.03M	249.18M	83.81M	177.81M	289.42M	452.70M	363.82M	482.27M	332.75M	503.92M	48.81M
Liabilities and Shareholders Equity (Quarter)	966.58M	1,025.86M	1,185.42M	1,104.43M	1,162.25M	1,781.39M	1,864.54M	1,841.51M	1,699.45M	1,810.44M	1,892.66M	1,733.27M	1,841.53M	1,969.45M	2,118.03M	2,063.48M	2,196.53M	2,053.90M	2,221.23M	2,525.32M
Retained Earnings (Quarter)	-433.73M	-0.02M	-125.68M	-0.62M	1.20M	-2.02M	-1.84M	143.22M	0.02M	-1.61M	1.23M	90.55M	-1.49M	-2.07M	397.63M	3.83M	477.96M	361.03M	502.15M	-18.09M
Treasury Shares (Quarter)	6.50M	1.04M	1.56M	3.90M			4.50M	4.50M	4.17M			0.24M	12.60M	19.10M		1.40M				1.52M

Research Tools

Halozyme Therapeutics Balance Sheet (2010-2025) | HALO

Create an account

Sign In

Reset Password